Respiratory Syncytial Virus News and Research

RSS
StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces investment report featuring GenVec

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Cardiology 2010 conference focuses on current treatments for children with heart disease

Cardiology 2010 conference focuses on current treatments for children with heart disease

Novavax to discontinue collaboration agreement with ROVI Pharmaceuticals

Novavax to discontinue collaboration agreement with ROVI Pharmaceuticals

Researchers identify antiviral small molecule that is effective against numerous viruses

Researchers identify antiviral small molecule that is effective against numerous viruses

Clinical results of MedImmune's pivotal trial for motavizumab published

Clinical results of MedImmune's pivotal trial for motavizumab published

Researchers develop automated system to differentiate strains of influenza

Researchers develop automated system to differentiate strains of influenza

Respiratory syncytial virus, the most common cause of pneumonia in children

Respiratory syncytial virus, the most common cause of pneumonia in children

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

RSV found to cause more emergency department visits and hospitalizations than seasonal flu

RSV found to cause more emergency department visits and hospitalizations than seasonal flu

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

Specimen Collection Kit to help medical personnel combat H1N1 and RSV

Specimen Collection Kit to help medical personnel combat H1N1 and RSV

Four abstracts on RSV and influenza prevention in pediatric health to be presented

Four abstracts on RSV and influenza prevention in pediatric health to be presented

3M launches new Rapid Detection Respiratory Syncytial Virus Test

3M launches new Rapid Detection Respiratory Syncytial Virus Test

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.